{
  "meta": {
    "title": "Drugs_Of_Abuse",
    "url": "https://brainandscalpel.vercel.app/drugs-of-abuse-fb57ab06.html",
    "scrapedAt": "2025-11-29T18:33:49.104Z"
  },
  "questions": [
    {
      "id": 14617,
      "choices": [
        {
          "id": 58429,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Side effects of hydrochlorothiazide</span></span></span></p>"
        },
        {
          "id": 58430,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased metabolism of hydrochlorothiazide by lithium.</span></span></span></p>"
        },
        {
          "id": 58431,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased renal tubular reabsorption of lithium.</span></span></span></p>"
        },
        {
          "id": 58432,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thiazide acts as an add on drug to lithium.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with bipolar disorder was treated with lithium. Hydrochlorothiazide was prescribed for his hypertension. He developed nausea, vomiting, coarse tremors and brisk reflexes 2 weeks after taking drugs. What is the likely reason for this presentation? </span></span></p>",
      "unique_key": "Q1324794",
      "question_audio": null,
      "question_video": null,
      "map_id": 36219,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Increased renal tubular reabsorption of lithium.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>most likely cause </strong>of the patient&#39;s symptoms, including<strong> nausea, vomiting, coarse tremors,</strong> and <strong>brisk reflexes,</strong> is <strong>increased renal tubular reabsorption</strong> of <strong>lithium.</strong> When <strong>hydrochlorothiazide, a thiazide diuretic, </strong>is <strong>administered</strong> <strong>alongside lithium,</strong> it can<strong> lead to</strong> <strong>decreased renal clearance of lithium</strong> by <strong>increasing its reabsorption in the renal tubules</strong>. This pharmacological interaction results in <strong>elevated serum lithium levels</strong>, potentially <strong>culminating</strong> in <strong>lithium toxicity.</strong> The <strong>symptoms of lithium toxicity </strong>closely align with <strong>those experienced by</strong> the<strong> patient,</strong> making this<strong> option</strong> the <strong>most plausible explanation</strong> for the clinical presentation observed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Side effects of hydrochlorothiazide:</span></strong><span style=\"font-size:12.0pt\"> While <strong>hydrochlorothiazide </strong>can cause side effects like <strong>electrolyte imbalances and dehydration</strong>, its <strong>common side effects do not</strong> typically include the combination of symptoms seen in<strong> lithium toxicity</strong> (<strong>nausea, vomiting, coarse</strong> <strong>tremors, and brisk reflexes</strong>). These<strong> symptoms </strong>are <strong>more specifically</strong> indicative of <strong>lithium</strong> <strong>toxicity</strong> <strong>rather than</strong> direct <strong>side effects of hydrochlorothiazide.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Decreased metabolism of hydrochlorothiazide by lithium:</span></strong><span style=\"font-size:12.0pt\"> Lithium <strong>does not</strong> significantly impact the<strong> metabolism of hydrochlorothiazide.</strong> The<strong> metabolism and clearance</strong> of <strong>hydrochlorothiazide </strong>are primarily<strong> renal</strong> and are <strong>not</strong> substantially <strong>altered by concurrent</strong> <strong>lithium use,</strong> making this option an <strong>unlikely cause </strong>of the<strong> patient&#39;s symptoms.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Thiazide acts as an add-on drug to lithium:</span></strong><span style=\"font-size:12.0pt\"> There is <strong>no</strong> evidence to suggest that thiazide diuretics <strong>act as add-on drugs to enhance the therapeutic effects of lithium</strong> in the treatment of <strong>bipolar disorder</strong>. The <strong>interaction between hydrochlorothiazide and lithium</strong> that is of clinical significance relates to the <strong>effect on lithium&#39;s renal handling</strong>, <strong>rather </strong>than a <strong>synergistic effect </strong>on <strong>mood stabilization.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The key learning point from this scenario is understanding the<strong> pharmacological interaction</strong> <strong>between lithium and thiazide diuretics</strong>, such as <strong>hydrochlorothiazide</strong>, and how this <strong>interaction</strong> can lead to <strong>increased serum lithium levels </strong>and <strong>subsequent lithium toxicity. </strong></span></span></p>",
      "correct_choice_id": 58431,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14493,
      "choices": [
        {
          "id": 57933,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Venlafaxine</span></span></span></p>"
        },
        {
          "id": 57934,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fluoxetine</span></span></span></p>"
        },
        {
          "id": 57935,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Valproate</span></span></span></p>"
        },
        {
          "id": 57936,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Olanzapine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stoppage of which of the following drugs can result in anxiety and insomnia causing discontinuation syndrome? </span></span></span></p>",
      "unique_key": "Q1604156",
      "question_audio": null,
      "question_video": null,
      "map_id": 36221,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\">Ans. A) Venlafaxine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><strong>Discontinuation syndrome</strong> refers to a<strong> set of symptoms</strong> that can occur after <strong>abruptly stopping or significantly reducing</strong> the <strong>dose of certain medications</strong>, particularly those that affect <strong>neurotransmitter levels </strong>in the brain such as <strong>antidepressants. </strong>&nbsp;Common <strong>symptoms of discontinuation syndrome </strong>include<strong> anxiety, insomnia, dizziness, irritability,</strong> <strong>flu-like symptoms, and sensory disturbances </strong>(e.g., &quot;<strong>electric shock&quot;</strong> sensations). The <strong>severity and</strong> <strong>duration</strong> of symptoms can vary depending on th<strong>e drug&#39;s half-life, dosage, and the duration of treatment</strong>. <strong>Discontinuation syndrome</strong> is commonly noted with all <strong>antidepressants</strong> including <strong>SSRI, SNRI and MAO inhibitors.</strong> It is <strong>less</strong> frequently noted with <strong>fluxoetine</strong> because of<strong> its long half life</strong>. <strong>Gradual tapering</strong> of the medication <strong>under medical</strong> <strong>supervision is recommended</strong> to<strong> minimize the risk</strong> of <strong>discontinuation syndrome.</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:&nbsp;Venlafaxine:</strong>&nbsp;It is an <strong>SNRI (serotonin-norepinephrine reuptake inhibitor),</strong> is known for its <strong>potent effects </strong>on <strong>both serotonin</strong> and <strong>norepinephrine reuptake</strong>. <strong>Discontinuation </strong>of<strong> venlafaxine</strong>, especially <strong>abruptly,</strong> can lead to a <strong>significant and distressing</strong> <strong>withdrawal</strong> syndrome characterized by<strong> anxiety, insomnia, and other physical and psychological symptoms. </strong>This is <strong>due to the rapid</strong> <strong>decline in neurotransmitter levels </strong>that had been maintained by the medication.</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Fluoxetine:</strong> <strong>Less </strong>likely to cause <strong>severe discontinuation syndrome</strong> due to <strong>its long half-life, </strong>which provides a <strong>natural</strong> <strong>tapering effect.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Valproate:</strong> An <strong>antiepileptic drug</strong> that<strong> does not</strong> typically cause <strong>discontinuation syndrome </strong>related to<strong> mood alterations</strong> like <strong>anxiety and insomnia.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Olanzapine:</strong> While<strong> stopping antipsychotics</strong> like<strong> olanzapine </strong>can lead to <strong>withdrawal symptoms</strong>, they <strong>do not</strong> typically manifest as <strong>anxiety and insomnia</strong> linked to <strong>discontinuation syndrome.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Venlafaxine</strong> <strong>discontinuation</strong> needs to be <strong>managed</strong> <strong>carefully to avoid severe withdrawal symptoms</strong>, often requiring a <strong>gradual</strong> <strong>tapering of the dose</strong> under medical supervision to <strong>mitigate the risk</strong> of<strong> discontinuation syndrome.</strong></span></span></p>",
      "correct_choice_id": 57933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14573,
      "choices": [
        {
          "id": 58253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carbamazepine</span></span></span></p>"
        },
        {
          "id": 58254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phenytoin</span></span></span></p>"
        },
        {
          "id": 58255,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phenobarbitone</span></span></span></p>"
        },
        {
          "id": 58256,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Valproate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which antiepileptic drug can cause this adverse effect?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture7.jpg\" style=\"height:227px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q1093531",
      "question_audio": null,
      "question_video": null,
      "map_id": 36224,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Phenytoin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Figure shows gum hypertrophy caused by Phenytoin. </span><span style=\"font-size:12.0pt\">Phenytoin is an antiepileptic drug known to cause gingival hyperplasia as a side effect. This adverse effect is more commonly associated with phenytoin than with the other antiepileptic drugs listed. The exact mechanism is not fully understood, but it is thought to involve the stimulation of fibroblasts to produce more collagen and other extracellular matrix substances, leading to the overgrowth of gum tissue.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Carbamazepine</span></strong><span style=\"font-size:12.0pt\">: While carbamazepine can have several side effects, it is not typically associated with gingival hyperplasia.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Phenobarbitone</span></strong><span style=\"font-size:12.0pt\">: Phenobarbitone (phenobarbital), another antiepileptic drug, also does not commonly cause gingival hyperplasia.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Valproate</span></strong><span style=\"font-size:12.0pt\">: Valproate does not typically cause gingival hyperplasia as a side effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The educational goal is to recognize the side effects associated with antiepileptic drugs, particularly phenytoin, which is known to cause gingival hyperplasia. Healthcare providers should monitor patients on phenytoin for this condition and educate them about maintaining good oral hygiene to help prevent or minimize this adverse effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drugs causing gum hypertrophy are:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phenytoin</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cyclosporine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium channel blockers like verapamil, diltiazem and nifedipine</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 58254,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14588,
      "choices": [
        {
          "id": 58313,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">More potently blocks 5HT2 as compared to D2 receptors.</span></span></span></p>"
        },
        {
          "id": 58314,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blood level below 350 ng/ml should be maintained to avoid agranulocytosis.</span></span></span></p>"
        },
        {
          "id": 58315,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Should not be used along with Carbamazepine.</span></span></span></p>"
        },
        {
          "id": 58316,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Should be discontinued if the WBC count is below 3,000/mm3 cells.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All are true about Clozapine except</span></span></span></p>",
      "unique_key": "Q9127716",
      "question_audio": null,
      "question_video": null,
      "map_id": 36229,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Blood level below 350 ng/ml should be maintained to avoid agranulocytosis.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The<strong> false</strong> statement about <strong>clozapine is option B, </strong>which states that <strong>&quot;Blood level below 350</strong> <strong>ng/ml </strong>should be maintained to <strong>avoid agranulocytosis.</strong>&quot; This statement is<strong> not true </strong>because there is <strong>no specific blood level of clozapine</strong> that is associated with the<strong> risk of agranulocytosis</strong>, which is<strong> dose-independent adverse effect of clozapine</strong>.<strong> High plasma</strong> <strong>concentration of Clozapine</strong> increases the<strong> risk of seizures (dose-dependent)</strong>. However, the usual <strong>plasma concentration </strong>required in many people is <strong>300-600 ng/ml.</strong></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Clozapine</strong> is an <strong>atypical antipsychotic</strong> drug that has <strong>high potency to block 5HT2</strong> <strong>receptors</strong> as <strong>compared to D2 receptors.</strong> However, it also<strong> blocks D4 receptors,</strong> <strong>muscarinic receptors, alpha receptors </strong>and <strong>H1 receptors. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It<strong> suppresses both positive</strong> as well as<strong> negative symptoms of schizophrenia</strong>. It is the<strong> first FDA</strong> approved drug for <strong>anti-suicide indication.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is used only as a<strong> reserve drug</strong> due to the<strong> risk of precipitation of seizures </strong>(<strong>even</strong> in<strong> non-epileptics</strong>) and<strong> agranulocytosis.</strong> <strong>Convulsions</strong> are <strong>dose-dependent </strong>adverse effects seen only<strong> at higher doses </strong>whereas <strong>agranulocytosis is independent</strong> of <strong>dose.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Clozapine</strong> should be <strong>started at low doses (12.5 mg) </strong>and <strong>gradually dose </strong>should be <strong>increased.</strong> <strong>Baseline WBC counts</strong> should be <strong>measured, </strong>and then <strong>weekly counts</strong> should be done<strong> at least for the first 6 months</strong>. When <strong>WBC count </strong>becomes <strong>less</strong> <strong>than 3000/mm3</strong> or <strong>absolute neutrophil </strong>count becomes<strong> less than 1500/mm3,</strong> <strong>Clozapine</strong> should be<strong> discontinued.</strong> <strong>After discontinuation,</strong> <strong>weekly WBC counts</strong> should be measured for an<strong> additional 4 weeks.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It should<strong> not</strong> be used with<strong> Carbamazepine</strong> due to two reasons:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Carbamazepine</strong> <strong>induces its metabolism </strong>and thus <strong>decreases plasma concentration.</strong></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Carbamazepine </strong>has<strong> bone marrow suppressant action </strong>and can add to <strong>agranulocytosis </strong>caused by <strong>Clozapine</strong>.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 58314,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14574,
      "choices": [
        {
          "id": 58257,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></span></p>"
        },
        {
          "id": 58258,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B </span></span></span></p>"
        },
        {
          "id": 58259,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C</span></span></p>"
        },
        {
          "id": 58260,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This figure represents the mechanism of drugs used in the treatment of parkinsonism. Which of the following options correctly represents the drugs shown in the figure?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture8.jpg\" style=\"height:373px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-170850.jpg\" style=\"height:301px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "unique_key": "Q6316085",
      "question_audio": null,
      "question_video": null,
      "map_id": 36225,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ans. C) A: Pramipexole, B: Entacapone, C: Selegiline, D: Carbi-dopa</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The mainstay of treatment for Parkinson&#39;s disease is the use of dopaminergic medications, which increase the levels of dopamine in the brain. These medications can be </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dopamine precursors: These medications are converted into dopamine in the brain and include levodopa (L-dopa) and its combination with carbidopa. Carbidopa prevents the breakdown of levodopa in the bloodstream (by inhibiting dopa decarboxylase enzyme), allowing more of it to reach the brain.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dopamine agonists: These medications mimic the action of dopamine in the brain and include pramipexole and ropinirole.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MAO-B inhibitors: These medications block the breakdown of dopamine in the brain and include selegiline and rasagiline. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Catechol-O-methyl transferase (COMT) inhibitors: These inhibit the metabolism of levo dopa and dopamine. These are used in0 combination with levodopa to prolong its effect. Examples of COMT inhibitors include entacapone and tolcapone.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture9.jpg\" style=\"height:303px; width:350px\" /></span></span></span></p>",
      "correct_choice_id": 58259,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14453,
      "choices": [
        {
          "id": 57773,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is less damaging to intima on intravenous administration.</span></span></span></p>"
        },
        {
          "id": 57774,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It can be injected in a drip of glucose solution.</span></span></span></p>"
        },
        {
          "id": 57775,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a prodrug of phenytoin.</span></span></span></p>"
        },
        {
          "id": 57776,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All the above</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fosphenytoin is different from phenytoin as?</span></span></span></p>",
      "unique_key": "Q1739266",
      "question_audio": null,
      "question_video": null,
      "map_id": 36227,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) All the above&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Fosphenytoin</strong> offers <strong>several advantages over phenytoin</strong>, particularly in how it <strong>is administered:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">It is a water-soluble prodrug of phenytoin</span></strong><span style=\"font-size:12.0pt\">, meaning it is <strong>converted into phenytoin once administered</strong>. This conversion allows it to be<strong> more versatile</strong> and <strong>manageable in clinical settings.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Less damaging to the vein intima</span></strong><span style=\"font-size:12.0pt\">: <strong>Fosphenytoin</strong> is <strong>less irritating to the veins </strong>compared to<strong> phenytoin,</strong> which is known for<strong> causing phlebitis</strong> and <strong>damage to the vein walls.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Can be mixed with glucose solutions</span></strong><span style=\"font-size:12.0pt\">: <strong>Unlike phenytoin</strong>, which <strong>precipitates in glucose solutions</strong>,<strong> fosphenytoin&rsquo;s water</strong> <strong>solubility</strong> allows it to be<strong> administered</strong> with various<strong> diluents</strong>, including <strong>glucose</strong>, <strong>enhancing its usability</strong> in different <strong>infusion setups.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">A, B, C</span></strong><span style=\"font-size:12.0pt\">: Each of these statements<strong> correctly</strong> describes how<strong> fosphenytoin differs from phenytoin</strong>, as detailed above.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fosphenytoin</strong> provides <strong>critical advantages </strong>for<strong> intravenous use over phenytoin,</strong> particularly its<strong> solubility, less vein irritation</strong>, and <strong>flexibility in dilution </strong>options, making it<strong> preferable</strong> in <strong>emergency and hospital settings</strong> for <strong>rapid seizure control.</strong></span></span></p>",
      "correct_choice_id": 57776,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14552,
      "choices": [
        {
          "id": 58169,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Furosemide</span></span></span></p>"
        },
        {
          "id": 58170,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diclofenac</span></span></span></p>"
        },
        {
          "id": 58171,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Morphine</span></span></span></p>"
        },
        {
          "id": 58172,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mannitol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 45-year-old male is brought to the emergency department following a motor vehicle accident. He has sustained a significant head injury, characterized by a loss of consciousness and visible head trauma. The medical team is evaluating his condition and considering management options.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Considering the patient&#39;s head injury, which of the following drugs is contraindicated due to the potential for exacerbating his condition?</span></span></span></p>",
      "unique_key": "Q7538638",
      "question_audio": null,
      "question_video": null,
      "map_id": 36223,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Morphine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the context of a significant<strong> head injury</strong> with a<strong> loss of consciousness and visible trauma,</strong> <strong>Morphine</strong> is <strong>contraindicated</strong> due to its <strong>potential to exacerbate the patient&#39;s condition</strong>.<strong> Morphine, an opioid analgesic</strong>, can lead to<strong> respiratory depression, </strong>resulting in <strong>increased carbon dioxide (CO2) levels</strong>. Elevated CO2 can cause<strong> cerebral vasodilation</strong>, leading to an<strong> increase in intracranial pressure</strong> (ICP), which is particularly<strong> dangerous in patients</strong> with <strong>head injuries</strong> as it can <strong>worsen brain injury </strong>and <strong>increase the risk of brain</strong> <strong>herniation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Furosemide</span></strong><span style=\"font-size:12.0pt\">: A<strong> diuretic</strong> used to<strong> reduce fluid overload</strong> but <strong>not</strong> typically <strong>contraindicated in head injury.</strong> It <strong>does not </strong>have the <strong>same impact on ICP as morphine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. &nbsp;Diclofenac</span></strong><span style=\"font-size:12.0pt\">: A <strong>non-steroidal anti-inflammatory drug (NSAID) </strong>used for<strong> pain management.</strong> While NSAIDs can have their <strong>own set of considerations in trauma</strong> (e.g., concerns <strong>about bleeding</strong>), they <strong>do not</strong> directly<strong> increase ICP like morphine can.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. &nbsp;Mannitol</span></strong><span style=\"font-size:12.0pt\">: An <strong>osmotic diuretic </strong>specifically <strong>used in the management </strong>of <strong>elevated ICP </strong>in patients with<strong> head injuries</strong>. <strong>Mannitol helps</strong> to <strong>reduce ICP</strong> and is<strong> indicated, not contraindicated,</strong> in cases of significant<strong> head trauma</strong> where <strong>increased ICP </strong>is a concern.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The key educational takeaway is to <strong>recognize the contraindication </strong>of <strong>using morphine</strong> in <strong>patients with head injuries</strong> due to its potential to <strong>cause respiratory depression, leading to increased CO2, cerebral vasodilation</strong>, and a subsequent <strong>rise in ICP. </strong></span></span></span></p>",
      "correct_choice_id": 58171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14462,
      "choices": [
        {
          "id": 57809,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a long acting &micro; -receptor agonist.</span></span></span></p>"
        },
        {
          "id": 57810,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is rapidly absorbed from the gastrointestinal tract and is detected in plasma 30 minutes after oral administration.</span></span></span></p>"
        },
        {
          "id": 57811,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The primary use of methadone is relief of chronic pain.</span></span></span></p>"
        },
        {
          "id": 57812,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The onset of analgesia is 60 minutes after parenteral administration and 2-4 hours after oral administration.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">True statements regarding methadone are all, except?</span></span></span></p>",
      "unique_key": "Q5863551",
      "question_audio": null,
      "question_video": null,
      "map_id": 36230,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) The onset of analgesia is 60 minutes after parenteral administration and 2-4 hours after oral administration.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Methadone,</strong> a<strong> long-acting &micro;-opioid receptor agonist, </strong>is known for its <strong>extended binding to the &micro;-opioid receptors</strong>, which provides <strong>prolonged pain relief </strong>as well as effects like<strong> sedation and euphoria.</strong> It is <strong>rapidly absorbed </strong>from the <strong>gastrointestinal tract,</strong> detectable in <strong>plasma within 30 minutes</strong> after <strong>oral administration</strong>. Its<strong> peak plasma concentrations </strong>and the <strong>onset of analgesia </strong>can vary among individuals but generally occur much sooner than stated in option D. Typically, the <strong>onset of analgesia</strong> is about<strong> 10-20 minutes after</strong> <strong>parenteral administration</strong> and <strong>30-60 minutes after oral administration, </strong>making<strong> option D incorrect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options A, B, C:</span></strong><span style=\"font-size:12.0pt\"> All are<strong> accurate statements</strong> about<strong> methadone</strong>, describing its<strong> pharmacokinetics and primary uses.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Methadone</strong> provides <strong>extended pain relief</strong> due to its <strong>long-acting nature </strong>as a<strong> &micro;-opioid receptor agonist.</strong> The<strong> onset </strong>of its <strong>analgesic</strong> <strong>effects</strong> is <strong>faster than </strong>indicated in<strong> option D</strong>, which is critical for understanding its<strong> effective use</strong> in <strong>pain management </strong>and <strong>opioid</strong> <strong>dependency treatments.</strong></span></span></span></p>",
      "correct_choice_id": 57812,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14468,
      "choices": [
        {
          "id": 57833,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parkinson&rsquo;s disease</span></span></span></p>"
        },
        {
          "id": 57834,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serotonin syndrome</span></span></span></p>"
        },
        {
          "id": 57835,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Neuroleptic malignant syndrome</span></span></span></p>"
        },
        {
          "id": 57836,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperpyrexia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mrs. Kanchan, a 50-year-old female, has been prescribed both clomipramine and escitalopram for the treatment of depression and anxiety. Which of the following should be monitored in her due to the combination of these medications?</span></span></span></p>",
      "unique_key": "Q1770942",
      "question_audio": null,
      "question_video": null,
      "map_id": 36210,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Serotonin Syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Serotonin syndrome </strong>is a<strong> critical condition</strong> to <strong>monitor</strong> in patients prescribed <strong>both clomipramine,</strong> a<strong> tricyclic antidepressant,</strong> and <strong>escitalopram, a selective serotonin reuptake inhibitor (SSRI)</strong>.<strong> Clomipramine inhibits </strong>the <strong>reuptake of serotonin</strong> and <strong>norepinephrine,</strong> while <strong>escitalopram</strong> primarily <strong>increases serotonin levels</strong> by<strong> inhibiting its reuptake </strong>at the<strong> synaptic cleft.</strong> The <strong>combined effect </strong>of these drugs significantly<strong> raises serotonin levels</strong>, which can lead to <strong>serotonin syndrome</strong>. This syndrome is characterized by<strong> symptoms such</strong> as <strong>agitation, confusion, rapid heart rate, dilated pupils, muscle rigidity, fever, </strong>and in severe cases, can be<strong> life-threatening.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Parkinson&rsquo;s disease:</span></strong><span style=\"font-size:12.0pt\"> <strong>Not</strong> directly related to the <strong>combined use of clomipramine and escitalopram.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Neuroleptic malignant syndrome:</span></strong><span style=\"font-size:12.0pt\"> Typically associated with the <strong>use of antipsychotic drugs,</strong> not antidepressants.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hyperpyrexia:</span></strong><span style=\"font-size:12.0pt\"> While hyperpyrexia can occur as a<strong> part of serotonin syndrome</strong>, it is <strong>not</strong> a<strong> standalone</strong> concern with these <strong>medications</strong> outside of that context.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When <strong>combining clomipramine</strong> <strong>with</strong> an<strong> SSRI like escitalopram</strong>, there is an <strong>increased risk of serotonin syndrome</strong>, a <strong>serious medical</strong> condition resulting from<strong> too much serotonin in the body.</strong> It is crucial to<strong> monitor for signs and adjust treatment </strong>if <strong>symptoms</strong> <strong>develop.</strong></span></span></span></p>",
      "correct_choice_id": 57834,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14470,
      "choices": [
        {
          "id": 57841,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Akathisia </span></span></span></p>"
        },
        {
          "id": 57842,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tardive dyskinesia </span></span></span></p>"
        },
        {
          "id": 57843,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rabbit syndrome </span></span></span></p>"
        },
        {
          "id": 57844,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute dystonia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 45-year-old male patient complained of hearing voices and was started on haloperidol for the treatment of his symptoms. However, for the past few days, he has been very restless and constantly moving about. What is the most likely condition that the patient is experiencing?</span></span></span></p>",
      "unique_key": "Q1754365",
      "question_audio": null,
      "question_video": null,
      "map_id": 36211,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Akathisia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Akathisia </strong>is a <strong>movement disorder</strong> commonly associated with the <strong>use of antipsychotic medications,</strong> such as <strong>haloperidol.</strong> It is characterized by an <strong>inner sense of restlessness</strong> and an <strong>uncontrollable </strong>need to be in <strong>constant motion.</strong> Patients often describe it as a <strong>compelling urge to move</strong>, and they are <strong>frequently seen shifting their position or walking about</strong>. This condition typically appears <strong>shortly </strong>after <strong>starting the medication</strong> or <strong>after a dose increase</strong>. <strong>Akathisia </strong>is<strong> distressing </strong>and <strong>can adversely affect</strong> compliance with <strong>medication.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tardive dyskinesia:</span></strong><span style=\"font-size:12.0pt\"> This condition involves<strong> involuntary, repetitive movements of the face and limbs </strong>but typically develops <strong>after long-term use of antipsychotics</strong>, making it<strong> less likely </strong>in this <strong>acute setting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Rabbit syndrome:</span></strong><span style=\"font-size:12.0pt\"> Characterized by<strong> rapid movements of the lips and mouth,</strong> <strong>rabbit syndrome</strong> is associated with <strong>prolonged antipsychotic use, not</strong> <strong>acute symptoms</strong> following<strong> recent medication initiation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Acute dystonia:</span></strong><span style=\"font-size:12.0pt\"> While this<strong> involves sudden muscle contractions,</strong> it usually presents as <strong>twisted postures or abnormal</strong> <strong>movements of the face, neck, and eyes</strong>, rather than the restlessness and constant movement typical of akathisia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Akathisia </strong>is a<strong> significant side effect </strong>of <strong>antipsychotic medications</strong> like<strong> haloperidol</strong>, presenting as an <strong>uncontrollable urge to move</strong> and <strong>restlessness</strong>, often occurring<strong> shortly after</strong> the<strong> initiation or increase of medication</strong>.<strong> Monitoring</strong> and managing this <strong>side effect</strong> are <strong>crucial for patient comfort</strong> and <strong>treatment adherence. Propranolol</strong> is<strong> frequently used </strong>to <strong>treat this condition effectively.</strong></span></span></span></p>",
      "correct_choice_id": 57841,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14506,
      "choices": [
        {
          "id": 57985,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antipsychotic</span></span></span></p>"
        },
        {
          "id": 57986,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-Depressants</span></span></span></p>"
        },
        {
          "id": 57987,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Selective serotonin reuptake inhibitors </span></span></span></p>"
        },
        {
          "id": 57988,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stimulants</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 12-year-old boy is referred to his physician because of &ldquo;blinking too much,&rdquo; which his mother thinks she first noted &gt;1 year ago. The boy states that he does not notice that it is occurring unless someone tells him about it. When he is nervous, it seems to worsen. He is embarrassed about it and wants to control it. What class of medications has been shown to worsen this condition? </span></span></span></p>",
      "unique_key": "Q2951384",
      "question_audio": null,
      "question_video": null,
      "map_id": 36222,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Stimulants</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The symptoms described are characteristic of <strong>Tourette syndrome,</strong> a condition marked by<strong> repetitive involuntary movements</strong> and vocalizations known as<strong> tics</strong>. <strong>Stimulants</strong>, commonly prescribed for conditions like <strong>ADHD,</strong> can <strong>exacerbate tics</strong> in individuals<strong> diagnosed</strong> <strong>with Tourette syndrome</strong>. The<strong> use of stimulants </strong>in patients with<strong> Tourette&#39;s needs careful consideration</strong>, as they can <strong>increase the</strong> <strong>frequency or severity of tics.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Antipsychotic:</span></strong><span style=\"font-size:12.0pt\"> These medications are <strong>sometimes used</strong> to<strong> manage severe tics</strong>, not worsen them.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Anti-Depressants:</span></strong><span style=\"font-size:12.0pt\"> Typically,<strong> do not exacerbate tics </strong>and are <strong>used to treat co-morbid conditions</strong> like<strong> anxiety or depression</strong> in <strong>Tourette syndrome.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Selective serotonin reuptake inhibitors (SSRIs):</span></strong><span style=\"font-size:12.0pt\"> <strong>Used</strong> to address associated <strong>symptoms of anxiety and depression </strong>but <strong>do</strong> <strong>not</strong> typically<strong> worsen tics.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When <strong>treating </strong>patients with <strong>Tourette syndrome</strong> who require medication for<strong> coexisting conditions</strong> such as <strong>ADHD,</strong> <strong>careful</strong> <strong>consideration</strong> must be given to the<strong> choice of medication</strong>, as<strong> stimulants may worsen tic symptoms.</strong></span></span></span></p>",
      "correct_choice_id": 57988,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14610,
      "choices": [
        {
          "id": 58401,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Thiamine</span></span></span></p>"
        },
        {
          "id": 58402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Diazepam</span></span></span></p>"
        },
        {
          "id": 58403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Lorazepam</span></span></span></p>"
        },
        {
          "id": 58404,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chlordiazepoxide</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of choice for delirium tremens in alcohol withdrawal in a patient with severe alcoholic liver disease is? </span></span></p>",
      "unique_key": "Q6537114",
      "question_audio": null,
      "question_video": null,
      "map_id": 36214,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Lorazepam</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Delirium tremens </strong>is a<strong> severe form </strong>of<strong> alcohol withdrawal syndrome</strong> that can be<strong> life-threatening. Benzodiazepines</strong> are the<strong> first-line treatment</strong> for managing<strong> alcohol withdrawal symptoms</strong>, including <strong>delirium tremens</strong>. However, in patients with<strong> severe liver disease,</strong> it is crucial to choose a<strong> benzodiazepine</strong> that is<strong> metabolized more safely </strong>in this population.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Lorazepam </strong>is preferred<strong> over</strong> other benzodiazepines like <strong>diazepam and chlordiazepoxide </strong>because it has a <strong>shorter half-life</strong> and<strong> undergoes glucuronidation, </strong>a metabolic pathway that is <strong>less affected </strong>by <strong>liver dysfunction</strong>. This makes <strong>lorazepam safe</strong>r for <strong>patients with impaired liver function.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Thiamine (vitamin B1) </strong>is important to<strong> administer in patients </strong>with <strong>alcohol use disorder</strong> to <strong>prevent Wernicke-Korsakoff</strong> <strong>syndrome</strong>, but it is <strong>not </strong>the treatment of for <strong>delirium tremens.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 58403,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14613,
      "choices": [
        {
          "id": 58413,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nausea and vomiting</span></span></span></p>"
        },
        {
          "id": 58414,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tremors</span></span></span></p>"
        },
        {
          "id": 58415,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypothyroidism</span></span></span></p>"
        },
        {
          "id": 58416,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypocalcemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The side effects of lithium in psychiatry practice includes all except? </span></span></p>",
      "unique_key": "Q7917218",
      "question_audio": null,
      "question_video": null,
      "map_id": 36215,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Hypocalcemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypocalcemia (low calcium levels in the blood) is not a side effect of lithium therapy. In rare cases, lithium may cause hyperparathyroidism and elevated parathyroid hormone levels, which can lead to hypercalcemia (elevated calcium levels in the blood).</span></span><br />\r\n</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>Other options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Lithium</strong> is a<strong> mood stabilizer </strong>commonly used in the <strong>treatment of bipolar disorder.</strong> The <strong>common side effects </strong>of<strong> lithium</strong> include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Nausea and vomiting</span></strong><span style=\"font-size:12.0pt\">: <strong>Gastrointestinal disturbances</strong>, such as <strong>nausea and vomiting,</strong> are common side effects of <strong>lithium</strong>, particularly during the<strong> initial stages of</strong> <strong>treatment.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tremors</span></strong><span style=\"font-size:12.0pt\">: <strong>Fine tremors</strong> are a<strong> well-known side effect of lithium therapy</strong>. These tremors may be<strong> dose-dependent</strong> and can be <strong>reduced by lowering the dose </strong>or by <strong>adding a</strong> <strong>beta-blocker.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hypothyroidism:</span></strong><span style=\"font-size:12.0pt\"> <strong>Lithium</strong> can interfere with <strong>thyroid function</strong>, leading to <strong>hypothyroidism </strong>in some patients.<strong> Regular monitoring </strong>of <strong>thyroid function </strong>is recommended during<strong> lithium treatment.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "correct_choice_id": 58416,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14614,
      "choices": [
        {
          "id": 58417,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dry mouth </span></span></span></p>"
        },
        {
          "id": 58418,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sexual&nbsp;</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">dysfunction</span></span></p>"
        },
        {
          "id": 58419,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Visual disturbance </span></span></span></p>"
        },
        {
          "id": 58420,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Constipation </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A psychotropic drug inhibiting the reuptake of serotonin is likely to cause which of the following side effects?</span></span></p>",
      "unique_key": "Q6487234",
      "question_audio": null,
      "question_video": null,
      "map_id": 36216,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Sexual dysfunction </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>SSRIs</strong> are commonly used to<strong> treat depression and anxiety disorders.</strong> They work by <strong>increasing the levels of serotonin</strong> in the brain, which helps<strong> regulate mood.</strong> However, <strong>SSRIs</strong> can also <strong>cause several side effects</strong>, including<strong> sexual dysfunction.</strong> This can manifest as<strong> decreased libido,</strong> <strong>difficulty achieving orgasm, or erectile dysfunction.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>other side effects</strong> listed <strong>(dry mouth, visual disturbance, and constipation)</strong> can be associated with <strong>other types of psychotropic medications</strong> but are <strong>not</strong> as commonly linked to<strong> serotonin reuptake inhibitors.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 58418,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14615,
      "choices": [
        {
          "id": 58421,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Depression</span></span></span></p>"
        },
        {
          "id": 58422,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insomnia</span></span></span></p>"
        },
        {
          "id": 58423,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Schizophrenia</span></span></span></p>"
        },
        {
          "id": 58424,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Epilepsy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mirtazapine is useful in the treatment of which of the following conditions? </span></span></span></p>",
      "unique_key": "Q4872240",
      "question_audio": null,
      "question_video": null,
      "map_id": 36218,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Depression</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MIRTAZAPINE</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Mirtazapine</strong> is an <strong>atypical antidepressant drug.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It <strong>inhibits presynaptic &alpha;2 receptors</strong> and thus<strong> increases NA and 5-HT release </strong>due to<strong> inhibition of auto- and hetero- receptors</strong>, respectively. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There is <strong>selective activation of 5-HT1 receptors</strong> due to <strong>antagonistic activity at 5-HT2 and 5-HT3 receptors</strong>. So, <strong>mirtazapine</strong> is also known as <strong>noradrenergic</strong> and <strong>specific serotonergic antidepressant (NSSA). </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It also has <strong>H1 blocking property, </strong>but <strong>not anticholinergic</strong> or <strong>antidopaminergic</strong> <strong>properties. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Side effects </strong>include <strong>sedation, weight gain, dizziness, lipid abnormalities. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Sexual dysfunction </strong>is <strong>not </strong>a problem with <strong>this drug.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 58421,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14457,
      "choices": [
        {
          "id": 57789,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Naloxone</span></span></span></p>"
        },
        {
          "id": 57790,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Naltrexone</span></span></span></p>"
        },
        {
          "id": 57791,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Buprenorphine</span></span></span></p>"
        },
        {
          "id": 57792,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nalmefene</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following acts as partial/weak &micro; agonist + k antagonist on opioid receptors?</span></span></span></p>",
      "unique_key": "Q6248414",
      "question_audio": null,
      "question_video": null,
      "map_id": 36228,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Buprenorphine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Buprenorphine</strong> is unique among <strong>opioids</strong> as it<strong> acts as a partial agonist at the &micro;-opioid receptor</strong> and a <strong>weak antagonist</strong> at the <strong>&kappa;</strong>-<strong>opioid receptor.</strong> Its <strong>partial agonist </strong>activity at the <strong>&micro; receptor</strong> allows it to produce<strong> analgesic effects</strong> <strong>similar to those of full agonists </strong>like<strong> morphine </strong>but with a <strong>ceiling effect </strong>that <strong>limits the maximum effect regardless of dose increase.</strong> This makes<strong> buprenorphine less</strong> likely to<strong> cause respiratory depression</strong>&mdash;a <strong>serious risk </strong>associated with<strong> full opioid agonists</strong>. Additionally, its <strong>weak antagonist activity</strong> <strong>at &kappa; receptors</strong> may contribute to <strong>its effectiveness</strong> in treating <strong>addiction without</strong> providing the <strong>full euphoric effects </strong>that are typically <strong>sough</strong>t by<strong> individuals using opioids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Naloxone:</span></strong><span style=\"font-size:12.0pt\"> This is a <strong>pure opioid antagonist</strong>, primarily used to<strong> reverse opioid overdose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Naltrexone:</span></strong><span style=\"font-size:12.0pt\"> Also an <strong>opioid antagonist,</strong> used in addiction treatment to <strong>block the effects of opioids and alcohol.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nalmefene:</span></strong><span style=\"font-size:12.0pt\"> An <strong>opioid antagonist</strong> used to manage<strong> alcohol dependence</strong>,<strong> not</strong> providing <strong>partial agonist effects at opioid</strong> <strong>receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Buprenorphine&rsquo;s partial agonist</strong> <strong>action at &micro;-opioid receptors </strong>combined with <strong>its weak &kappa; antagonism </strong>makes it an<strong> effective option</strong> for <strong>opioid addiction treatment, reducing potential abuse</strong> while managing <strong>withdrawal and dependence symptoms.</strong></span></span></span></p>",
      "correct_choice_id": 57791,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14486,
      "choices": [
        {
          "id": 57905,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Levetiracetam </span></span></span></p>"
        },
        {
          "id": 57906,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Phenytoin</span></span></span></p>"
        },
        {
          "id": 57907,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vigabatrin </span></span></span></p>"
        },
        {
          "id": 57908,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ethosuximide</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male patient with a history of seizures presents to the clinic. He has been taking anticonvulsants for the last few years, and he reports experiencing visual disturbances, including a narrowing of his visual field. He is concerned about the possibility of permanent vision loss. Which of these anticonvulsants causes contraction of visual field? </span></span></p>",
      "unique_key": "Q1260861",
      "question_audio": null,
      "question_video": null,
      "map_id": 36217,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Vigabatrin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Vigabatrin </strong>is an<strong> anticonvulsant </strong>known for <strong>its mechanism </strong>of action as a <strong>GABA transaminase inhibitor,</strong> which <strong>increases the level of</strong> <strong>gamma-aminobutyric acid (GABA)</strong> in the<strong> brain</strong>, <strong>beneficial</strong> for <strong>controlling seizures.</strong> However, a significant <strong>side effect </strong>associated <strong>with</strong> <strong>vigabatrin </strong>is the <strong>contraction of the visual field,</strong> which can be <strong>severe and </strong>is often <strong>irreversible.</strong> This <strong>adverse effect </strong>necessitates <strong>regular and careful monitoring of visual function </strong>in patients <strong>using vigabatrin, </strong>particularly those who <strong>report visual disturbances</strong>, as these<strong> could indicate</strong> the <strong>onset of this irreversible side effect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A. Levetiracetam:</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Does not&nbsp;</strong>commonly cause<strong> visual field changes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Phenytoin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Known for <strong>different side effects</strong>, <strong>primarily </strong>affecting the<strong> CNS and skin</strong>, <strong>not</strong> specifically<strong> linked to visual field</strong> <strong>contraction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ethosuximide:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Used<strong> primarily for absence seizures </strong>and<strong> does not</strong> typically cause <strong>visual field changes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Vigabatrin</strong>, while <strong>effective for controlling </strong>certain <strong>types of seizures,</strong> carries a<strong> risk of </strong>causing <strong>permanent visual field contraction,</strong> <strong>underscoring</strong> the <strong>need for regular ophthalmologic monitoring</strong> in patients <strong>undergoing this treatment.</strong></span></span></span></p>",
      "correct_choice_id": 57907,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14474,
      "choices": [
        {
          "id": 57857,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a specific antagonist of benzodiazepines.</span></span></span></p>"
        },
        {
          "id": 57858,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It may be used to treat barbiturate poisoning.</span></span></span></p>"
        },
        {
          "id": 57859,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is given intravenously.</span></span></span></p>"
        },
        {
          "id": 57860,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It acts on the same site on GABA channel where benzodiazepines bind.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mr. Atiq, a 40-year-old man, presents to the emergency department with symptoms of benzodiazepine overdose. He has a history of anxiety and has been taking benzodiazepines for several months. The medical team decides to administer flumazenil to reverse the effects of benzodiazepines. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All the following statements about flumazenil are true EXCEPT</span></span></span></p>",
      "unique_key": "Q5411038",
      "question_audio": null,
      "question_video": null,
      "map_id": 36212,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) It may be used to treat barbiturate poisoning.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Flumazenil</strong> is a <strong>specific antagonist</strong> for<strong> benzodiazepines,</strong> meaning it <strong>reverses their effects</strong> by <strong>competitively binding</strong> to the <strong>benzodiazepine receptor site on the GABA-A receptor complex. </strong>It is <strong>administered intravenously,</strong> often in<strong> cases of overdose</strong> or to <strong>hasten </strong>recovery from <strong>benzodiazepine sedation in medical settings</strong>. Crucially,<strong> flumazenil</strong> <strong>does not</strong> counteract the effects of <strong>barbiturates</strong>, as these<strong> drugs do not act </strong>at the<strong> benzodiazepine binding site</strong> but rather have a <strong>distinct modulatory effect on the GABA-A receptor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options A, C, D:</span></strong><span style=\"font-size:12.0pt\"> These statements<strong> correctly </strong>describe<strong> flumazenil&rsquo;s</strong> <strong>pharmacological characteristics</strong> and <strong>mode of action.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Flumazenil </strong>is<strong> effective</strong> in<strong> reversing benzodiazepine effects</strong> but is<strong> not</strong> suitable for <strong>treating barbiturate poisoning</strong> due to <strong>different</strong> <strong>sites of action on the GABA-A receptor complex.</strong></span></span></p>",
      "correct_choice_id": 57858,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14491,
      "choices": [
        {
          "id": 57925,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sialorrhea </span></span></span></p>"
        },
        {
          "id": 57926,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vivid dreams </span></span></span></p>"
        },
        {
          "id": 57927,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nausea </span></span></span></p>"
        },
        {
          "id": 57928,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anorgasmia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 38-year-old male with a history of depression and anxiety is started on escitalopram. After a week, he reports excessive drooling, vivid dreams, and mild nausea. He is concerned about these symptoms and asks you which of the following is not an adverse effect of escitalopram?</span></span></span></p>",
      "unique_key": "Q3487432",
      "question_audio": null,
      "question_video": null,
      "map_id": 36220,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Sialorrhea</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Escitalopram</strong> belongs to a group of<strong> anti-depressant drugs </strong>called <strong>Selective Serotonin Reuptake Inhibitors (SSRI). </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is the active (S) enantiomer of citalopram. </span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Sialorrhea or excessive salivation</strong> is <strong>not</strong> a known <strong>adverse effect of escitalopram.</strong> It is important to remember from MCQ point that the only important drug used in CNS that causes<strong> sialorrhea is clozapine.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Vivid dreams and nausea </strong>are<strong> </strong><strong>common side effects of escitalopram,</strong> and <strong>anorgasmia</strong> is a <strong>potential sexual side effect </strong>like all <strong>SSRIs.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 57925,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14577,
      "choices": [
        {
          "id": 58269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\">Mu </span></span></span></p>"
        },
        {
          "id": 58270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\">Kappa</span></span></span></p>"
        },
        {
          "id": 58271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\">Delta </span></span></span></p>"
        },
        {
          "id": 58272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\">Sigma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dysphoria caused by opiates is mediated by which receptor? </span></span></span></p>",
      "unique_key": "Q4051240",
      "question_audio": null,
      "question_video": null,
      "map_id": 36226,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\">Ans. B) Kappa</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The dysphoria caused by opiates is mediated by the kappa opioid receptor. The kappa receptor is one of the three major classes of opioid receptors (the other two being mu and delta) and is found throughout the central and peripheral nervous systems.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When activated, the kappa receptor produces a variety of effects, including analgesia, dysphoria, and sedation. The dysphoric effects of kappa receptor activation are thought to be due to its effects on the reward pathway in the brain, which can lead to feelings of discomfort, anxiety, and aversion.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In contrast, activation of the mu opioid receptor is associated with the pleasurable effects of opioids, including pain relief and euphoria. The delta receptor is less well understood but is thought to play a role in the modulation of pain perception and mood.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 58270,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14609,
      "choices": [
        {
          "id": 58397,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fluvoxamine</span></span></span></p>"
        },
        {
          "id": 58398,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sertraline</span></span></span></p>"
        },
        {
          "id": 58399,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Citalopram</span></span></span></p>"
        },
        {
          "id": 58400,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mirtazapine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old teacher began to experience changes in mood. He was losing interest in his work and lacked the desire to play his daily tennis match. He was preoccupied with feelings of guilt, worthlessness, and hopelessness. In addition to the psychiatric symptoms, the patient complained of muscle aches throughout his body. Physical and laboratory tests were unremarkable. After 6 weeks of therapy with fluoxetine, his symptoms resolved. However, the patient complains of sexual dysfunction. Which of the following drugs might be useful in this patient? </span></span></p>",
      "unique_key": "Q6371340",
      "question_audio": null,
      "question_video": null,
      "map_id": 36213,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Mirtazapine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case, the<strong> patient </strong>has <strong>experienced sexual dysfunction</strong> as a<strong> side effect of fluoxetine,</strong> a <strong>selective serotonin reuptake</strong> <strong>inhibitor (SSRI).</strong> <strong>Switching</strong> to <strong>another medication</strong> with a <strong>lower risk of sexual side effects</strong> may be<strong> helpful. </strong>Most <strong>typical antidepressants</strong> including<strong> SSRI, SNRI, MAO inhibitors and TCA </strong>can cause <strong>sexual adverse effects,</strong> so <strong>atypical</strong> <strong>antidepressant drugs</strong> are<strong> better </strong>option in this <strong>patient. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Other Options:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Option A,Option B and Option C : Fluvoxamine, Sertraline and Citalopram are SSRI </strong>which may also<strong> cause sexual side effects</strong> whereas<strong> Mirtazapine</strong> is an <strong>atypical antidepressant</strong> that acts as an <strong>antagonist at alpha-2 adrenergic receptors</strong> and <strong>serotonin receptors (5-HT2 and 5-HT3).</strong> It has a<strong> lower risk </strong>of causing <strong>sexual side effects </strong>compared to <strong>SSRIs.</strong></span></span></span></p>",
      "correct_choice_id": 58400,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}